MCRI On-X Looks To Revive Mechanical Heart Valve Market
This article was originally published in The Gray Sheet
Executive Summary
Preliminary data demonstrating whether MCRI's On-X mechanical heart valve can be used with minimal anti-coagulation therapy will be available in the second or third quarter of 2004, the firm says
You may also be interested in...
Edwards, St. Jude Pursue Opposite Pricing Strategies For New Tissue Valves
St. Jude Medical does not expect a significant price premium for its BioCor and Epic porcine tissue heart valves upon U.S. approval, anticipated in 2004 and 2006, respectively, the firm says
Edwards, St. Jude Pursue Opposite Pricing Strategies For New Tissue Valves
St. Jude Medical does not expect a significant price premium for its BioCor and Epic porcine tissue heart valves upon U.S. approval, anticipated in 2004 and 2006, respectively, the firm says
SJM Epic Porcine Valve Trial Signals Turnaround Of St. Jude’s Valve Business
St. Jude expects the introduction of its BioCor stented porcine tissue valve in the U.S. later this year to lead a roughly 13% turnaround of the firm's replacement heart valve business in 2003